rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

GeoVax Labs, Inc.

GOVX · Nasdaq

Health CareBiotechnologyNot moving yet

GOVX stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 77.7% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
16 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$26KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders16+2 on the quarter
New · exited5 · 3
Reported value$466K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
JANE STREET GROUP, LLCnew · filed 14 Aug 2026315,275$400K+315,275
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 202621,112$27K-14,964−41.5%
TWO SIGMA SECURITIES, LLCnew · filed 14 Aug 202610,682$14K+10,682
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 20265,068$6,43600.0%
Tower Research Capital LLC (TRC)reduced · filed 11 Aug 20263,502$4,448-25−0.7%
VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 20263,217$4,08600.0%
SBI Securities Co., Ltd.added · filed 23 Jul 20262,588$3,287+2,204+574.0%
MORGAN STANLEYadded · filed 13 Aug 20262,003$2,544+1,997+33283.3%
JONES FINANCIAL COMPANIES LLLPnew · filed 14 Aug 20261,000$1,320+1,000
UBS Group AGreduced · filed 13 Aug 2026944$1,199-3,304−77.8%
31 Mar 2024 – 30 Jun 2026
101520Mar 24Sep 24Jun 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

David A. Dodd Company insiderPresident, CEO · last 17 Jun 202611 · 0
Dean G. Kollintzas Company insiderDirector · last 17 Jun 20262 · 0
Jayne Morgan Company insiderDirector · last 17 Jun 20260 · 0
John N. Spencer Jr. Company insiderDirector · last 17 Jun 20269 · 0
John W. Sharkey Company insiderVP, Business Development · last 17 Jun 20262 · 0
Kelly T. McKee Jr. Company insiderChief Medical Officer · last 17 Jun 20266 · 0
Mark J. Newman Company insiderChief Scientific Officer · last 17 Jun 20261 · 0
Mark Reynolds Company insiderCFO · last 17 Jun 202614 · 0
Nicole Lemerond Company insiderDirector · last 17 Jun 20260 · 0
Randal D. Chase Company insiderDirector · last 17 Jun 20265 · 0
Robert T. McNally Company insiderDirector · last 17 Jun 20269 · 0
Farshad Guirakhoo Company insiderChief Scientific Officer · last 17 Dec 20180 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 2025-869%
Free cash flow marginFY 2025 · to 31 Dec 2025-864%
Share count trendFY 2025 · to 15 Apr 202667.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$3.1M
Free cash flowFY 2025 · to 31 Dec 2025−$21.5M

Analyst forecasts

No analyst forecasts yet.